LClose 1.82 Price 1.85
Change 0.03 (1.65%) Low 1.85
High 2.00 EPS 0.04
PE 30.90 Shares Outs. 1,899,157,108
52WkHigh 2.57 52WkLow 0.37
50d Mov Avg 1.49 200d Mov Avg 0.92
AvgDlyVol 1,221,443.78 3MthChg 1.21 (189.06%)
6MthChg 1.35 (270.00%) 12MthChg 1.30 (236.36%)
Div. Yield 2.7027 Risk Factor 0.007316892
Sector Pharmaceuticals
Company Profile

Neimeth International pharmaceuticals plc engages in the manufacture and marketing of pharmaceutical, animal health, and general health care products in Nigeria. It offers consumer products, including analgesics, anthemintiasis, anti-stress/multivitamin, antimalarial/protozoal, antiseptic, and pediatric products; ethical products, which include anti-bacterial, anti-diabetic, anti-fungal, anti-hypertensive, anti-rheumatic, sedative, and sickle cell products; and veterinary products, which include anthelministics, antibiotics, and vitamins. The company offers its products in various forms, such as powders, capsules, syrups, tablets, and creams. It also offers contract manufacturing/analysis services. The company sells its products through distributors. Neimeth International pharmaceuticals plc was founded in 1957 and is headquartered in lkeja, Nigeria. Website: www.neimethplc.com Founded in: 1957

Income statement

Statement of Comprehensive Income as at

Name Amount
Revenue 2,269,004.00
Profit before taxation 202,479.00
Taxation 18,444.00
Profit/(loss) after tax 184,035.00
Transfer to revenue reserve 184,035.00
Profit attributable to:
Owners of the company
Non-controlling interest
Earnings per 50k share (k) 11.00
Net assets per 50k share (k) 57.00
Board of directors
Name Title
Ambrose Orjiako Non-Executive Chairman of the Board
Ebere Ekpunobi Managing Director/Chief Executive Officer
Christopher Mmeje Executive Director - Finance
Adekunle Adebowale Manager
Isaac Igbanoi Manager
Olufemi Ojakoya Manager
Roseline Oputa Manager
Florence Onyenekwe Secretary
A. Balogun Non-Executive Director
Maurice Iwu Non-Executive Director
Godfrey Ohuabunwa Non-Executive Director
Mazi Ohuabunwa Non-Executive Director